Single-Cell Multiomics Market, by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics) by Application (Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research), By End-Use (Academic Institutes, Contract Research Organizations, other ), and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Single-Cell Multiomics Маrkеt Overview

The global Single-Cell Multiomics Маrkеt is projected to reach USD 18,359.6 Mn by 2031 at a CAGR of 21.40%, from USD 2,640.4 Mn in 2021.

“Global Single-Cell Multiomics Market, by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics) by Application (Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research), By Technique (Single Cell Isolation and Dispensing, Single Cell Analysis), By End-Use (Academic Institutes, Contract Research Organizations, Pharmaceutical, and Biotech Companies), and by Region – Global Forecast to 2031”. This report offers a holistic view of the global single-cell multiomics market through systematic segmentation that covers every aspect of this target market.

Multi-omics is the study of the interactions between different molecules within a cell. This approach is used to understand how the cell functions as a whole. Single-cell multi-omics allows for the analysis of individual cells, providing insights into cellular heterogeneity. This technology can identify different cell types and track their development. In multi-omics, the study of the interactions between different types of molecules within a cell, single-cell analysis has become increasingly important. This is because single cells can now be isolated and studied more easily. In addition, technological advances have made it possible to sequence and map the genomes of individual cells. By understanding individual cells’ genomic diversity, researchers can comprehensively understand cellular function and behavior.

Single-cell multi-omics is a rapidly growing field of study that uses genomic, transcriptomic, proteomic, and metabolomics techniques to profile the molecular state of individual cells. This approach can reveal new insights into the biology of cells and tissues and could lead to the development of new diagnostic and therapeutic strategies. Single-cell multi-omics is an up-and-coming technology that combines single-cell sequencing with other omics technologies to get a more comprehensive view of the cellular makeup of a tissue or organism. This approach has already been used greatly in cancer research, where tumor heterogeneity makes traditional bulk analysis approaches ineffective. Single-cell multi-omics can identify different subpopulations of cells within a tumor and determine their gene expression profiles and functional characteristics.

The technological advances in single-cell sequencing have revolutionized biology and medicine. The ability to sequence the genome of a single cell has provided new insights into the biology of cells and tissues. However, using single-cell sequencing for multi-cellular organisms is fraught with challenges. One of the major challenges is identifying cells responsible for a particular phenotype or disease state. Additionally, there is a lack of standardization between various laboratories.

Global Single-Cell Multiomics Market Revenue (US$ Mn), 2021–2031

Source: Prudour, 2021

Technological developments in single-cell analysis products, as well as an increase in the number of large-scale genomics research using single-cell RNA sequencing, are leading to the further expansion of the single-cell multi-omics market (sc-RNA). Furthermore, increasing disposable incomes, particularly in emerging countries, and the increased adoption of customized medicine for genetic condition screening and diagnosis, propel the single-cell multi-omics market forward. Personalized therapy has the potential to simplify the clinical and molecular complexity of these illnesses, which are linked to high mortality rates and high healthcare costs. Furthermore, this could provide useful tools for preventive tactics and probable disease progression indications. It could also help predict morbidity, mortality, and chronic disease markers earlier in the progression. Moreover, the expansion of various initiatives and collaborations between pharmaceutical and biotechnology firms and research institutes all play an important role in augmenting market growth prospects. Moreover, this industry has been further complemented by a significant increase in healthcare expenditures on a global scale. The increase in populations, particularly geriatric individuals, and greater medical service consumption for early diagnosis of genetic abnormalities are two main factors driving up healthcare costs. These are certain factors that will aid in fueling this market in the years to come.

However, the expansion of this market is anticipated to be hindered by the high costs of single-cell analysis and a lack of significant online data storage and analysis platforms.

Increased collaborations and funding in single-cell multi-omics research are expected to create good growth possibilities for key global single-cell multi-omics market players.

Furthermore, the COVID-19 outbreak is expected to influence the single-cell multi-omics industry positively. A large number of clinics and hospitals around the world have been reconfigured to boost hospital capacities to be able to deal with the influx of COVID-19 patients. Due to this substantial increase in cases, non-essential or elective procedures have been put on the back-burner. The manufacturing and distribution of healthcare essentials were disrupted due to lockdowns. Other issues negatively influencing this market include a lack of medical treatment, a shortage of healthcare workers, and increased COVID-19-related hospitalizations. On the other hand, single-cell multi-omics has had a positive impact on a host of healthcare services. According to healthcare professionals, the single-cell multi-omics market is one of the most rapidly evolving. Furthermore, this global market is driven by a surge in chronic disorders such as cancer and infectious diseases caused by viruses. The research into single-cell multi-omics for COVID-19 could help this target market grow exponentially in the foreseeable future.

This research report on the global single-cell multi-omics market includes major company profiles such as

• 10x Genomics Inc.
• Becton
• Dickinson and Company
• Berkeley Lights Inc.
• BGI Genomics Co. Ltd.
• Bio Rad Laboratories Inc.
• Danaher Corporation (Cytiva Life Sciences)
• Dolomite Bio
• Epicypher Inc.
• Fluidigm Corporation
• Illimina Inc.
• Miltenyi Biotec B.V. & CO.
• Mission Bio Inc.
• Nanostring Technologies Inc.
• Olink Holding AB (Olink Proteomics)
• Parse Bioscience
• Qiagen N.V.
• Takara Holdings Inc. (Takara Bio Group)
• Thermo Fischer Scientific Inc., among others.

The Global Single-Cell Multiomics Market Segmentation Based on Type, Application, Technique, End-Use, and Region

Based on Type

• Single Cell Genomics
• Single Cell Proteomics
• Single Cell Transcriptomics
• Single Cell Metabolomics

Based on Application

• Oncology
• Cell Biology
• Neurology
• Immunology
• Stem Cell Research

Based on Technique

• Single Cell Isolation and Dispensing
• Single Cell Analysis

Based on End-Use

• Academic Institutes
• Contract Research Organizations
• Pharmaceutical and Biotech Companies

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

For the Single Cell Multiomics Маrkеt research study, the following years have been considered to estimate the market size: